| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edgewise Therapeutics, Inc. (EWTX) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. EWTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 262.5K | $9.34M | - | |
| Other | 105.0K | $3.74M | - | |
| Dir | 45.1K | $1.61M | - | |
| CEO | 38.6K | $1.37M | - | |
| Dir | 30.0K | $1.07M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Donovan Joanne M.53 | CMO | Sale+OE | 55,230 | $37.88 | $2,092,062.91 | -86.3% | - | - | |
| Mar 31, 2026 | Donovan Joanne M.53 | CMO | Sale+OE | 21,338 | $32.12 | $685,308.28 | -69.0% | - | - | |
| Mar 27, 2026 | Donovan Joanne M.53 | CMO | Sell | 16,358 | $30.98 | $506,734.85 | -38.7% | - | - | |
| Nov 12, 2025 | Russell Alan J78 | Chief Scientific Officer | Sale+OE | 100,000 | $21.12 | $2,112,450.00 | -81.0% | +46.4% | - | |
| Nov 11, 2025 | Fox Jonathan C | - | Buy | 10,700 | $18.64 | $199,403.06 | +82.3% | +40.8% | - | |
| Aug 26, 2025 | Russell Alan J78 | Chief Scientific Officer | Sale+OE | 100,000 | $14.60 | $1,459,760.00 | -81.0% | +60.8% | - | |
| Aug 12, 2025 | Moore John R45 | General Counsel | Sale+OE | 2,098 | $13.39 | $28,097.26 | -17.0% | +36.5% | - | |
| Aug 12, 2025 | Derakhshan Behrad54 | Chief Business Officer | Sale+OE | 2,491 | $13.39 | $33,360.47 | -9.5% | +36.5% | - | |
| Aug 12, 2025 | Carruthers R Michael51 | Chief Financial Officer | Sale+OE | 1,428 | $13.39 | $19,124.35 | -1.6% | +36.5% | - | |
| Aug 12, 2025 | Koch Kevin58 | President And CEO | Sale+OE | 7,972 | $13.39 | $106,764.21 | -20.7% | +36.5% | - |